Literature DB >> 4192704

Immune complexes in rheumatoid synovitis: a mixed staining immunofluorescence study.

L Bonomo, A Tursi, D Trizio, U Gillardi, F Dammacco.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4192704      PMCID: PMC1455492     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


× No keyword cloud information.
  22 in total

1.  HEMOLYTIC COMPLEMENT IN SYNOVIAL FLUID.

Authors:  T J PEKIN; N J ZVAIFLER
Journal:  J Clin Invest       Date:  1964-07       Impact factor: 14.808

2.  LYSOSOMES, AUTOIMMUNE PHENOMENA, AND DISEASES OF CONNECTIVE TISSUE.

Authors:  G WEISSMANN
Journal:  Lancet       Date:  1964-12-26       Impact factor: 79.321

3.  A SPECULATION ON THE PATHOGENESIS OF JOINT INFLAMMATION IN RHEUMATOID ARTHRITIS.

Authors:  N J ZVAIFLER
Journal:  Arthritis Rheum       Date:  1965-04

4.  HEBERDEN ORATION, 1964. SOME IMMUNOLOGIC ASPECTS OF THE CONNECTIVE TISSUE DISEASES.

Authors:  M ZIFF
Journal:  Ann Rheum Dis       Date:  1965-03       Impact factor: 19.103

5.  Isothiocyanate compounds as fluorescent labeling agents for immune serum.

Authors:  J L RIGGS; R J SEIWALD; J H BURCKHALTER; C M DOWNS; T G METCALF
Journal:  Am J Pathol       Date:  1958 Nov-Dec       Impact factor: 4.307

6.  An Immunofluorescence Study of Rheumatoid Factor.

Authors:  J N McCormick
Journal:  Ann Rheum Dis       Date:  1963-01       Impact factor: 19.103

7.  Zymosan coated particles used to prepare anti-beta-1C.

Authors:  F Stratton
Journal:  Vox Sang       Date:  1966 Mar-Apr       Impact factor: 2.144

8.  Distribution of the anti-gamma globulin factors in the synovial membrane and other tissues in various diseases.

Authors:  L Bonomo; A Tursi; U Gillardi
Journal:  Ann Rheum Dis       Date:  1968-03       Impact factor: 19.103

9.  The potentiating effect of rheumatoid arthritis serum in the immediate phase of nephrotoxic nephritis.

Authors:  J N McCormick; J Day; C J Morris; A G Hill
Journal:  Clin Exp Immunol       Date:  1969-01       Impact factor: 4.330

10.  Serum complement, rheumatoid factor, and other serum proteins in rheumatoid disease and systemic lupus erythematosus.

Authors:  H A ELLIS; D FELIX-DAVIES
Journal:  Ann Rheum Dis       Date:  1959-09       Impact factor: 19.103

View more
  18 in total

1.  Demonstration of antiglobulin activity in the synovial membrane of patients with rheumatoid arthritis and ankylosing spondylitis after pepsin treatment: real or artefact?

Authors:  P G Davies; P A Revell; V Mayston
Journal:  Ann Rheum Dis       Date:  1986-10       Impact factor: 19.103

2.  Complement activation by the alternative pathway and macrophage enzyme secretion in the pathogenesis of chronic inflammation.

Authors:  H U Schorlemmer; D Bitter-Suermann; A C Allison
Journal:  Immunology       Date:  1977-06       Impact factor: 7.397

3.  The roles of IgG, IgM rheumatoid factor, and their complexes in the induction of polymorphonuclear leukocyte chemotactic factor from complement.

Authors:  T Wagner; G Abraham; J Baum
Journal:  J Clin Invest       Date:  1974-06       Impact factor: 14.808

4.  Pathology, pathogenesis, and aetiology of rheumatoid arthritis.

Authors:  L E Glynn
Journal:  Ann Rheum Dis       Date:  1972-09       Impact factor: 19.103

5.  Elution of antiglobulins and antinuclear antibody from rheumatoid synovial membrane.

Authors:  A Cracchiolo; L S Goldberg
Journal:  Ann Rheum Dis       Date:  1972-05       Impact factor: 19.103

6.  Immunopathological changes in rheumatoid arthritis and other joint diseases.

Authors:  T Ghose; J F Woodbury; S Ahmad; B Stevenson
Journal:  J Clin Pathol       Date:  1975-02       Impact factor: 3.411

Review 7.  Antibody-dependent and -independent mechanisms of inflammatory arthritis.

Authors:  Margaret H Chang; Peter A Nigrovic
Journal:  JCI Insight       Date:  2019-03-07

8.  Histopathology of the synovial membrane of peripheral joints in ankylosing spondylitis.

Authors:  P A Revell; V Mayston
Journal:  Ann Rheum Dis       Date:  1982-12       Impact factor: 19.103

9.  Immunosuppressive therapy in the rheumatic diseases.

Authors: 
Journal:  Can Med Assoc J       Date:  1971-12-04       Impact factor: 8.262

10.  Self-associating IgG rheumatoid factors stimulate monocytes to release prostaglandins and mononuclear cell factor that stimulates collagenase and prostaglandin production by synovial cells.

Authors:  F A Nardella; J M Dayer; M Roelke; S M Krane; M Mannik
Journal:  Rheumatol Int       Date:  1983       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.